This manuscript details experiments showing that the FALCs in the pericardium and mediastinum support IgM producing cells following infection with Litomosoides sigmondontis (Ls). Ls-specific IgM increased specifically in the pleural cavity and FALCs were significantly expanded in size and number after infection. Various B cell populations were modestly expanded, but the numbers of plasma cells were dramatically expanded in the pericardium following infection. IL-33 is important for control of Ls and in the absence of IL-33R, FALCs were decresed in size and the overall numbers of cells were reduced both before and after infection. IL-33R-deficiency impaired plasma cell formation and IgM secretion. The mediastinum was an important source of IL-33 (similar to lung). The authors also tested the role of FALCs and IL-33R in response to a fungal pathogen, Alternaria and observed similar results. Interestingly, although the B cell response was reduced in the absence of IL-33R, B cells did not respond directly to IL-33 and instead required IL-5.
infection and lung inflammation" Jackson-Jones and colleagues investigate the role of B cells in Fat-associated Lymphoid Clusters (FALCs) in the pleural cavity. The authors describe an unexpected role for the mediastinal FALCs in innate immune responses in pleural nematode infection and lung inflammation, where IL-33, produced by adipose tissue stromal cells, activates group 2 innate lymphoid cells (ILC2) that produce IL-5 needed for pleural B1 cell activation and IgM production.
The current study is a continuum of an earlier one from the same authors demonstrating inflammation-induced expansion and activation of FALCs and FALC-associated B cells. However the notion of a large population of IgM+ B cells in the peritoneal and pleural cavities is not novel, their function has remained elusive. Jackson-Jones et al. have used two models of pleural inflammation characterizing B1 cell activation in FALCs. The most significant finding of the study is that pleural FALC sense and respond to lung inflammation, suggesting their FALC and FALC B cell involvement in various pathological conditions of the lung, such as infections, allergies or asthma.
The following points are raised:
• As the Ls parasite model is not widely used, would be great to have more details about infection, such as parasite burden on different days when samples were acquired. Also, references to relevant literature using the Ls model are missing (Babayan et al, Infection and Immunity 2003) or others.
• How relevant are B cells and IgM for Ls resistance? Some discussion of proof of this would be valuable.
• Figure 1 includes data acquired at several different timepoints, such as day 8, day 11 and day 18. What is the reasoning for that? What does it mean for the infection with Ls (parasite burden)?
• The mesenteric and pericardial adipose compartments are populated by ILC2s. ILC2s react to IL-33 and other epithelial factors induced by parasite infection by proliferation and production of IL-13 and IL-5. Is there an expansion/activation of ILC2 during Ls infection? • Lung type 2 pneumocytes constitutively express IL-33 at high levels that is release rapidly upon infection, such as Nippostrongylus brasiliensis or lung inflammation (papain) model for example. The data in Figure 4 demonstrated that per g of tissue the mediastinum produces similar amount of IL-33 compared to the lung. However, in infection situation, there is so much more lung tissue that releases IL-33, making the relevance of IL-33 from FALC questionable.
• The data in Figure 4 to claim that IL-33 derives from stromal cell is weak. Why not use mesenteric FALCs as a comparison? It is known that GAT has little FALCs and is a very distant non-relevant tissue. Were negative/positive controls performed for the immunostaining? The data should be complemented by analyzing tissues from Ls infected animals.
• On Figure 5e it is evident that p Lavage provides folds more IgM than pl lavage even at steady state. This is not consistent with Fig.1 , where total IgM levels at steady state in p lavage is close to 0. This should be discussed.
• What other cells produced IL-5 in the pericardium/lung? Do lung ILC2 produce IL-5?
• It is surprising that that ILC2s which are central in the story linking IL-33 and B cell-produced IgM, received so little attention in the analysis. Some inclusion of this analysis would improve the manuscript.
• The biological importance of the pathways described is not evident from the data presented. There is no connection to pathogen resistance or tissue protection in inflammation. Loss-offunction and gain-of-function experiments are missing for a high-impact journal! Minor concerns:
• • The term 'FALC' is sometimes confusing in the text as it is hard to understand which compartment is under discussion 'mediastinal FALC' or 'pericardial FALC' 'pleural FALC'. Page 10 talks about FALCs but figure 4 says "mediastinum". On figure 5 mediastinum has turned into 'mediastina". The is confusing to the reader.
Reviewer #1
Expert in pulmonary immune responses (Remarks to the Author):
1. The differentiation of PCs in IL-33R-/-mice seems not as poor as the authors want us to believe. In figure 3C , there is a huge population of SSChiIgDlo cells in the IL-33R-/-mice. The absolute numbers go down (probably because the total inflammatory infiltrate goes down), but their ability to differentiate seems fine.
We entirely agree with the analysis of the reviewer. Figure 6 and the following paragraph added to the text:
"As eosinophils are the other main target of IL-5 3, 4 , we wanted to assess the contribution of eosinophils to the induction of B cell proliferation and IgM secretion. First, we analysed the impact of the delivery of anti-IL-5 antibody in the pleural cavity. As expected, we found a reduction in the number of eosinophils within the pleural exudate and a trend for reduced eosinophilia within the pericardial FALCs. However, this did not reach significance (Fig. 6h) We concur that aIL-5 does deplete eosinophils in the pleural cavity, however we do not see a significant reduction in the FALCs themselves. These data have been added to In this study we clearly showed that during Ls infection, the levels of IgM rose only in the pleural cavity and not the serum or the peritoneal cavity, which indicated that IgM was secreted only in the pleural cavity (Figure 1a-b) . In this cavity, we demonstrated that only B cells in FALCs were competent to produce antibody as shown by our in vitro culture study ( Figure 1g ). We believe that this evidence though not entirely direct is strong. It is not currently possible to eliminate FALCs in the pleural cavity. Surgical removal of the pericardium is possible but total removal of FALC containing adipose is not.
Furthermore, such surgery would disrupt the pleural membranes where the nematode resides. We could use intra-pleural injection of anti-CD19 antibody to deplete B cells, however this wouldn't be a specific depletion of the cells in the FALCs but would target fluid phase B-cells as well, and thus we don't feel such experiments would add any new information to our manuscript.
7. The authors focus on IgM, however, IgE is also an important Ig isotype in these infections. Is IgE produced in the FALCs?
We typically have been unable to detect IgE within the substantial (2ml) volume of pleural lavage fluid that we routinely assessed and therefore had not pursued this isotype. However, because of the reviewers comment,
we put the entire mediastinum in culture and tested for Is there any mechanistic difference between filarial infection model and Alternaria model?
The two models we used are mechanistically very different. In the first model, the highly motile parasites are physically resident within the pleural cavity, whereas in the second 2) It is intriguing why the authors did not examine the antigen-specific response in Alternaria model. In Fig. 5e and f, the authors should show Alternaria-specific IgM titers in addition to the concentration of total IgM.
We do not find any antigen specific IgM at 48h following Alternaria instillation, we believe that this time point is too early for an antigen specific response to have been generated.
3) In Fig. 6f , there seem to be two populations in anti-IL-5 treated group; half of population was not really affected by the anti-IL-5 treatment. Why?
Yes, we noted this as well. The immunofluorescence analysis in Figure 6f includes the % area of Ki67 within whole 'FALCs' and not specifically B-cells within FALCs as assessed by flow-cytometry, thus non B-cell types within the clusters are the most likely explanation for this population that exhibits higher Ki67, and are unaffected by anti-IL-5 treatment.
4) ILC2 is able to produce IL-5 in response to PMA and ionomycin even in naïve mice. IL-33 produced by Alternaria treatment is expected to induce the proliferation of ILC2s Therefore, the authors should show the absolute number of IL-5+ ILC2s in Fig. 6h .
We have removed the ILC data from Figure 6 and the absolute numbers of ILC2s have now been added to the new Figure 7 that also includes additional Ls ILC data. This paragraph has been added to the text:
FALC ILC2s increase following induction of pleural inflammation
Finally, we determined the cellular origin of IL-5 in pericardial FALCs during Ls infection by analyzing the intra-cellular levels of IL-5 within digested pericardium from C57BL/6 mice. We found here that Lineage -CD90. 5) Antigen-specific IgM is produced by FALC cells but not PLEC cells (Fig. 1g ) but cell numbers in PLEC increased by Alternaria treatment (Fig. 5c, d ), indicating that cells were mobilized to pleural cavity. It is intriguing that whereas adoptive transfer of PLEC cells resulted in the migration of B cells to FALC, antigen-specific B cells do not come out from the FALC to the pleural cavity. Where do PLEC cells come from? Are they from blood stream?
We believe that antigen-specific B cells are competent to migrate from the FALCS to the pleural cavity but when they do they are no longer able to produce antibodies since this 6) In Fig. 7 , please add explanation of T, H, and L, which seem to be thymus, heart and lung.
We apologize for this oversight; the explanations for T, H and L have now been added to the figure legend for Fig 8 (previously Fig 7) 7) On page 4 th line, "Type 2" Innate Lymphoid Cells should be "Group 2" Innate Lymphoid Cells.
We have exchanged the word Type for the word Group in the text. • How relevant are B cells and IgM for Ls resistance? Some discussion of proof of this would be valuable.
We have added a discussion of the evidence for B cells and IgM for Ls resistance to the discussion. In somewhat more detail:
IgM has been shown to be important for protection against infection with filarial worms in both experimental models 6 and human studies are grossly imparied in the BALB/c μMT strain 11 . As these mice only lack IgM (unlike the C57BL/6 μMT) it suggests that IgM is needed for proper worm development. We are excited to unravel this complicated system in future work but feel that it is currently outside the scope of this manuscript. We hope to acquire reagents and mouse lines in the future that will allow us to address the role of secreted IgM in resistance to this infection. We believe that the contribution of pleural FALCs to local IgM production remains an important novel finding.
The following paragraph has been added to the discussion: 29 and thus it will be important to use more refined models to determine whether IgM recognition facilitates parasite killing by macrophages, as has been described in a related parasite model 41 .
To be honest, Day 8, 11 and 18 were chosen because our initial hypothesis was that FALCs would be a major site of macrophage proliferation and these time points straddle the peak of proliferation. However, we made the novel discovery that FALCs were instead important site for B cell proliferation and antibody production. Nonetheless, we believe these are relevant time points as they allow us to assess the response at a stage of infection, when there is no significant difference in parasite burden between susceptible and resistant strains.
We have modified the following sentence in the text with the inclusion of additional references:
We chose to assess resistant C57BL/6 mice at days 8-18 post infection, a time prior to immune mediated parasite killing but at which point an active immune response is occurring in the pleural cavity 28, 29
• The mesenteric and pericardial adipose compartments are populated by ILC2s. ILC2s react to IL-33 and other epithelial factors induced by parasite infection by proliferation and production of IL-13 and IL-5. Is there an expansion/activation of ILC2 during Ls infection?
We have added new data to Figure 7 showing that ILC2s are increased in the pericardial FALCs during Ls infection (Fig. 7a-d) . The text has been modified as shown in response to reviewer 2, question 4.
Lung type 2 pneumocytes constitutively express IL-33 at high levels that is release rapidly upon infection, such as Nippostrongylus brasiliensis or lung inflammation (papain) model for example. The data in Figure 4 demonstrated that per g of tissue the mediastinum produces similar amount of IL-33 compared to the lung. However, in infection situation, there is so much more lung tissue that releases IL-33, making the relevance of IL-33 from FALC questionable.
We acknowledge that following major lung infection/inflammation total levels of IL-33 will be higher in this tissue, but we don't believe that this IL-33 will have a relevant role in the Indeed, our data highlight this point as we don't observe a full proliferative response in Bcells of the pleural cavity during either Ls or alternaria.
The mesenteric adipose has comparatively few FALCs in comparison to the omental adipose (see Benezech et al 2015) , and thus omentum was used as a positive control.
We used the GAT as a negative control site that lacks clusters, enabling us to extrapolate that IL-33 expression is linked to stromal cells within FALC containing tissues and not within adipose depots with a more dispersed immune network. In Figure   4 c-f we have now expanded our analysis of FALC stromal cell IL-33 production. This new data includes flow cytometric analysis of digested pericardium, including secondary only controls for IL-33 staining, whole mount immunofluorescence staining for IL-33 also including secondary only controls and ELISA analysis of mediastinum IL-33 release from both naïve and day 11 Ls infected C57BL/6 mice.
We have modified the text as follows:
'We next addressed whether FALC stromal cells contained IL-33 during Ls infection (Fig. 4c) .
Flow cytometric analysis of digested pericardial FALCs confirmed that >95% of CD45 -GP38 + stromal cells from C57BL/6 mice expressed intracellular IL-33 (Fig. 4d ) compared to only ~2% of CD45 + cells, when gated based on a secondary antibody only control (Fig. 4d) . At day 11
following Ls infection, no difference in the levels of IL-33 within stromal or haematopoietic cells was detected by flow cytometry (Fig. 4d) , ELISA analysis of spontaneous IL-33 release during 1h
in vitro culture of the mediastinum (Fig. 4e) or whole mount immunoflouresence staining as compared to naive controls (Fig. 4f )'
The explanation for the difference is that the data in Figure 1 are from C57BL/6 mice, while the data in Figure 5e are from BALB/c mice. A key point is that the peritoneal lavage reflects the serum IgM and naïve C57BL/6 animals have markedly lower levels of serum IgM (~10 μg) than naïve BALB/c animals (3 mg). The important finding is that in contrast to the pleural lavage, there is no increase in the amounts of IgM in the peritoneal lavage following Ls infection or Alternaria instillation, with the peritoneal lavage mirroring the serum response (though folds lower in the C57BL/6 mice).
• (Fig. 7a) . ILCs expressed significantly more IL-5 than all other cell populations assessed (Fig. 7b )'
• It is surprising that that ILC2s which are central in the story linking IL-33 and B cellproduced IgM, received so little attention in the analysis. Some inclusion of this analysis would improve the manuscript.
We have added additional ILC data from both Ls and Alternaria to revised Figure 7 .
Please see above for changes made to the text.
• The biological importance of the pathways described is not evident from the data presented. There is no connection to pathogen resistance or tissue protection in inflammation. Loss-of-function and gain-of-function experiments are missing for a highimpact journal! We have spent considerable time considering how to directly address the role of the FALCs in resistance vs susceptibility to this parasite. The most obvious step, to specifically ablate the FALCs of the pleural space, is simply not possible. The use of B cell KOs is compromised as discussed above. However, we are excited to unravel this complicated system in future work and our next step will be to acquire mouse lines that will allow us to address the role of secreted IgM in resistance to this infection. However, as discussed above, the results may not provide immediate or straightforward answers.
We believe our finding that pleural FALCs are a critical site for local IgM production remains an important novel finding with implications for a variety of conditions beyond this parasite model.
Minor concerns:
• Fig 1c to supplementary figures . This is not part of relevant findings We believe that most readers will not be familiar with these tissues and that their visual identification in figure 1c, will help with understanding. We can move this to the supplementary section if required.
• Figure 2a has no Ki67-posiitve B220+ cells, however this is claimed in the text.
Although the zoomed area of figure 2a which focuses on the strongly IgM positive region of the FALC has no B220+Ki67+ B cells, these cells are evident above and to the right of the white box in the middle panel of figure 2a.
• Page 8, line 4 of 2nd paragraph word 'plasmablasts' misses an 's'. Same passage, line 10, 'pericardial' noncapitalize.
These errors have been corrected in the text.
• The term 'FALC' is sometimes confusing in the text as it is hard to understand which compartment is under discussion 'mediastinal FALC' or 'pericardial FALC' 'pleural FALC'. Page 10 talks about FALCs but figure 4 says "mediastinum". On figure 5 mediastinum has turned into 'mediastina". The is confusing to the reader.
We have altered Figure 5 so that it now reads Mediastinum rather than Mediastina and have modified the text in an attempt to be more consistent
For the most part the authors have appropriately addressed my previous comments. I still believe that proof of the the essential role of the mediastinal/pericardial FALCs is lacking (point 6), but as the authors point out, selectively eliminating the FALCs may be technically impossible. As a result, we have to rely on circumstantial evidence, which are reasonably compelling.
Reviewer #2 (Remarks to the Author):
Jackson-Jones et al. revised their paper with new experimental data. The authors promptly addressed most of the points raised by reviewers and the paper is much improved. There are still several minor points that need to be addressed.
1) The authors labeled PLEC with CFSE and CTV in the experiments shown in Fig. 6 and page 13. The cell composition of PLEC is unclear. The authors should provide the composition of PLEC such as X% of B1a, Y% of B1b, Z% of B2 etc. In addition, the authors should describe how they identified B1 cells in these experiments when they analyzed transferred cells.
2) The 4th line on page 7, PLEC should be spelt out here instead of those on the 12th line.
3) The 3rd line on page 10, (Fig. 3e) should be (Fig. 3e,f) .
4) The 6th line from the bottom of page 15, (Fig. 7D) should be (Fig. 7d ).
5) The 4th line from the bottom of page 15, (Fig. 7f) should be cited after "Alt instillation" or "did not reach significance".
6) At the end of the first paragraph of Discussion, (Fig. 7) should be ( Fig. 8 ).
7) The 8th line of page 17, (Fig. 3A-D) should be ( Fig. 3a-d ).
8) In
Materials and Methods, it should be described how many generations the authors backcrossed the Il1rl1-/-and ΔdblGATA mice to BALC/c background.
9) The 5th line from the bottom of page 21, figure 7c should be figure 7b.
10) Although the authors mentioned in the legend for Fig. 2 that symbols in (a) represent individual clusters, there are no symbols but a square demonstrating the area for enlargement.
Reviewer #3 (Remarks to the Author):
Comments on the rebuttal letter from Jackson-Jones et al.
In general, the authors have significantly improved the manuscript by including novel data and modifying the text to facilitate an uninformed reader. I understand that gain-and loss-of-function experiments to address functional relevance of FALCs in physiology and infection are technically complicated due to unavailability of tools. However, I have some minor comments on modifications:
1) It is surprising that there is no change in IL-5-producing ILC2s, whereas, there is an increase in ILC2 numbers in the tissue upon Ls infection or alternaria. Is there a change when analyzing ILC2 proportions to CD45+ cells? The data on Fig. 7 is presented as change of FMO control staining that is very misleading at first glance. Raw MFI would be more informative. You are demonstrating fold change but apparently there is none when comparing naïve vs. infected condition. The rate of IL-5+ ILC2s is very high, higher than published for ILC2s in any other condition. Therefore, this data warrants for comparison with some tissue earlier published to include IL-5+ ILC2s, such as the colon.
2) On figure 4 you demonstrate the difference in IL-33 release from different tissues. Does IL-5 follow the same pattern? The ILC2s in FALC seem to be highly activated according to your data.
Reviewer #1 (Remarks to the Author):
Reviewer #2 (Remarks to the Author):
The text and figure legend has been amended as shown below:
In the results section p13:
"To test this, we labeled total PLEC from BALB/c and Il1rl1 -/-donor mice with CFSE and Cell Trace Violet (CTV) respectively, co-injected labeled PLEC into the pleural space of a recipient BALB/c animal, instilled Alt 18h later and compared the CFSE (WT) and CTV (Il1rl1 -/-) labeled B cell populations after 48h (Fig. 6a) 2) The 4th line on page 7, PLEC should be spelt out here instead of those on the 12th line.
We have now corrected this in the text. 
